GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (OTCPK:CXXIF) » Definitions » Research & Development

C21 Investments (C21 Investments) Research & Development : $0.00 Mil (TTM As of Oct. 2023)


View and export this data going back to . Start your Free Trial

What is C21 Investments Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. C21 Investments's Research & Development for the three months ended in Oct. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Oct. 2023 was $0.00 Mil.


C21 Investments Research & Development Historical Data

The historical data trend for C21 Investments's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Research & Development Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

C21 Investments Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (OTCPK:CXXIF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


C21 Investments Research & Development Related Terms

Thank you for viewing the detailed overview of C21 Investments's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (C21 Investments) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (C21 Investments) Headlines

From GuruFocus

C21 Addresses Market Conditions to Shareholders

By PRNewswire PRNewswire 03-13-2020

C21 Announces Significant Expansion to Nevada Cultivation

By PRNewswire PRNewswire 12-02-2020

C21 Investments to acquire Grön Chocolate and Confections

By PRNewswire PRNewswire 08-15-2018

C21's Nevada Dispensaries Achieve Record Retail Revenue for Q2

By PRNewswire PRNewswire 08-04-2020

C21 Investments Announces Q1 Results

By PRNewswire PRNewswire 08-13-2020

C21 Completes Restructured Phantom Farms Acquisition

By PRNewswire PRNewswire 02-20-2020

C21 Investments Announces Year End Results

By PRNewswire PRNewswire 07-14-2020